Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 10Sarcoma 4

Conditions

Gliosarcoma 7Glioblastoma 7Central Nervous System Neoplasms 7Brain Neoplasms 7Astrocytoma 6Oligodendroglioma 4Glioma 3Medulloblastoma 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Temozolomide 32Radiotherapy 11Magnetic Resonance Spectroscopy 11Carboplatin 10Bevacizumab 10Irinotecan 9Carmustine 9Filgrastim 8Erlotinib Hydrochloride 8Surgical Procedures, Operative 7sargramostim 5Imatinib Mesylate 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 52,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5temsirolimus 4Vorinostat 4Sirolimus 4Procarbazine 4Peripheral Blood Stem Cell Transplantation 4O(6)-benzylguanine 4aldesleukin 3Thalidomide 3Iodine-125 3Immunohistochemistry 3Gadolinium DTPA 3Cyclophosphamide 3Bortezomib 3Biopsy 3lonafarnib 2imetelstat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Oligodendroglioma × Procarbazine × Sarcoma × Clear all
NCT00079092 2021-09-09

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Wake Forest University Health Sciences

Phase 2 Completed
18 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT00004004 2013-06-21

Procarbazine in Treating Patients With Recurrent Brain Tumor

National Cancer Institute (NCI)

Phase 1/2 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003564 2012-02-22

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

M.D. Anderson Cancer Center

Phase 3 Withdrawn
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡